Journey Medical Corp Net Income
| DERM Stock | USD 7.73 0.02 0.26% |
As of the 13th of February 2026, Journey Medical retains the Market Risk Adjusted Performance of (0.31), standard deviation of 3.56, and Risk Adjusted Performance of (0.04). Journey Medical technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Journey Medical Corp market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Journey Medical is priced fairly, providing market reflects its last-minute price of 7.73 per share. Given that Journey Medical Corp has information ratio of (0.08), we strongly advise you to confirm Journey Medical Corp's regular market performance to make sure the company can sustain itself at a future point.
Journey Medical Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 4.4794 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -16.9 M | -17.7 M | |
| Net Loss | -13.2 M | -13.9 M | |
| Net Loss | -26.7 M | -25.3 M | |
| Net Loss | (0.65) | (0.68) | |
| Net Income Per E B T | 0.90 | 0.76 |
Journey | Net Income | Build AI portfolio with Journey Stock |
Evaluating Journey Medical's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Journey Medical Corp's fundamental strength.
Latest Journey Medical's Net Income Growth Pattern
Below is the plot of the Net Income of Journey Medical Corp over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Journey Medical Corp financial statement analysis. It represents the amount of money remaining after all of Journey Medical Corp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Journey Medical's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Journey Medical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (14.67 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Journey Net Income Regression Statistics
| Arithmetic Mean | (57,028,661) | |
| Coefficient Of Variation | (144.47) | |
| Mean Deviation | 54,608,159 | |
| Median | (31,875,000) | |
| Standard Deviation | 82,387,842 | |
| Sample Variance | 6787.8T | |
| Range | 308.5M | |
| R-Value | 0.16 | |
| Mean Square Error | 7053.4T | |
| R-Squared | 0.03 | |
| Significance | 0.54 | |
| Slope | 2,621,164 | |
| Total Sum of Squares | 108604.1T |
Journey Net Income History
Other Fundumenentals of Journey Medical Corp
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Journey Medical Net Income component correlations
Journey Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Journey Medical is extremely important. It helps to project a fair market value of Journey Stock properly, considering its historical fundamentals such as Net Income. Since Journey Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Journey Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Journey Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Biotechnology sector continue expanding? Could Journey diversify its offerings? Factors like these will boost the valuation of Journey Medical. Projected growth potential of Journey fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Journey Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.35) | Revenue Per Share | Quarterly Revenue Growth 0.205 | Return On Assets | Return On Equity |
Understanding Journey Medical Corp requires distinguishing between market price and book value, where the latter reflects Journey's accounting equity. The concept of intrinsic value - what Journey Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Journey Medical's price substantially above or below its fundamental value.
It's important to distinguish between Journey Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Journey Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Journey Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Journey Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Journey Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Journey Medical.
| 11/15/2025 |
| 02/13/2026 |
If you would invest 0.00 in Journey Medical on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding Journey Medical Corp or generate 0.0% return on investment in Journey Medical over 90 days. Journey Medical is related to or competes with OrganiGram Holdings, Cartesian Therapeutics, China SXT, Fennec Pharmaceuticals, Helius Medical, Orchestra BioMed, and Inventiva. Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatmen... More
Journey Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Journey Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Journey Medical Corp upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 16.43 | |||
| Value At Risk | (5.29) | |||
| Potential Upside | 4.4 |
Journey Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Journey Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Journey Medical's standard deviation. In reality, there are many statistical measures that can use Journey Medical historical prices to predict the future Journey Medical's volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.24) | |||
| Total Risk Alpha | (0.51) | |||
| Treynor Ratio | (0.32) |
Journey Medical February 13, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.04) | |||
| Market Risk Adjusted Performance | (0.31) | |||
| Mean Deviation | 2.63 | |||
| Coefficient Of Variation | (1,893) | |||
| Standard Deviation | 3.56 | |||
| Variance | 12.71 | |||
| Information Ratio | (0.08) | |||
| Jensen Alpha | (0.24) | |||
| Total Risk Alpha | (0.51) | |||
| Treynor Ratio | (0.32) | |||
| Maximum Drawdown | 16.43 | |||
| Value At Risk | (5.29) | |||
| Potential Upside | 4.4 | |||
| Skewness | (0.86) | |||
| Kurtosis | 4.18 |
Journey Medical Corp Backtested Returns
As of now, Journey Stock is somewhat reliable. Journey Medical Corp holds Efficiency (Sharpe) Ratio of 0.0179, which attests that the entity had a 0.0179 % return per unit of risk over the last 3 months. We have found twenty-two technical indicators for Journey Medical Corp, which you can use to evaluate the volatility of the firm. Please check out Journey Medical's Market Risk Adjusted Performance of (0.31), standard deviation of 3.56, and Risk Adjusted Performance of (0.04) to validate if the risk estimate we provide is consistent with the expected return of 0.0554%. Journey Medical has a performance score of 1 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 0.61, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Journey Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Journey Medical is expected to be smaller as well. Journey Medical Corp right now retains a risk of 3.1%. Please check out Journey Medical total risk alpha, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Journey Medical will be following its current trending patterns.
Auto-correlation | 0.51 |
Modest predictability
Journey Medical Corp has modest predictability. Overlapping area represents the amount of predictability between Journey Medical time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Journey Medical Corp price movement. The serial correlation of 0.51 indicates that about 51.0% of current Journey Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.51 | |
| Spearman Rank Test | 0.19 | |
| Residual Average | 0.0 | |
| Price Variance | 0.29 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Journey Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Journey Medical Corp reported net income of (14.67 Million). This is 104.3% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 102.57% higher than that of the company.
Journey Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Journey Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Journey Medical could also be used in its relative valuation, which is a method of valuing Journey Medical by comparing valuation metrics of similar companies.Journey Medical is currently under evaluation in net income category among its peers.
Journey Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Journey Medical from analyzing Journey Medical's financial statements. These drivers represent accounts that assess Journey Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Journey Medical's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Enterprise Value | 159.9M | 45.0M | 24.6M | 95.3M | 109.6M | 106.4M |
Journey Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Journey Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Journey Medical's managers, analysts, and investors.Environmental | Governance | Social |
Journey Medical Institutional Holders
Institutional Holdings refers to the ownership stake in Journey Medical that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Journey Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Journey Medical's value.| Shares | Opaleye Management Inc | 2025-06-30 | 95 K | Northern Trust Corp | 2025-06-30 | 85 K | Envestnet Asset Management Inc | 2025-06-30 | 70 K | Legato Capital Management Llc | 2025-06-30 | 68 K | Geneos Wealth Management Inc | 2025-06-30 | 63.3 K | Integrated Wealth Concepts Llc | 2025-06-30 | 55.4 K | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 51.9 K | Atria Investments Llc | 2025-06-30 | 37.2 K | Gladstone Institutional Advisory Llc | 2025-06-30 | 32.9 K | Tang Capital Management Llc | 2025-06-30 | 1.9 M | Wasatch Advisors Lp | 2025-06-30 | 1.2 M |
Journey Fundamentals
| Return On Equity | -0.47 | ||||
| Return On Asset | -0.046 | ||||
| Profit Margin | (0.15) % | ||||
| Operating Margin | (0.09) % | ||||
| Current Valuation | 266.07 M | ||||
| Shares Outstanding | 27.26 M | ||||
| Shares Owned By Insiders | 24.33 % | ||||
| Shares Owned By Institutions | 32.76 % | ||||
| Number Of Shares Shorted | 2.56 M | ||||
| Price To Earning | (9.50) X | ||||
| Price To Book | 10.26 X | ||||
| Price To Sales | 4.47 X | ||||
| Revenue | 56.13 M | ||||
| Gross Profit | 39.23 M | ||||
| EBITDA | (8.4 M) | ||||
| Net Income | (14.67 M) | ||||
| Cash And Equivalents | 38.14 M | ||||
| Cash Per Share | 2.17 X | ||||
| Total Debt | 25.7 M | ||||
| Debt To Equity | 0.61 % | ||||
| Current Ratio | 1.40 X | ||||
| Book Value Per Share | 0.98 X | ||||
| Cash Flow From Operations | (9.13 M) | ||||
| Short Ratio | 18.42 X | ||||
| Earnings Per Share | (0.35) X | ||||
| Price To Earnings To Growth | (0.04) X | ||||
| Target Price | 13.5 | ||||
| Number Of Employees | 41 | ||||
| Beta | 0.82 | ||||
| Market Capitalization | 265.72 M | ||||
| Total Asset | 80.24 M | ||||
| Retained Earnings | (87.03 M) | ||||
| Working Capital | 13 M | ||||
| Current Asset | 217.23 M | ||||
| Current Liabilities | 25.9 M | ||||
| Net Asset | 80.24 M |
About Journey Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Journey Medical Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Journey Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Journey Medical Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Will Biotechnology sector continue expanding? Could Journey diversify its offerings? Factors like these will boost the valuation of Journey Medical. Projected growth potential of Journey fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Journey Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.35) | Revenue Per Share | Quarterly Revenue Growth 0.205 | Return On Assets | Return On Equity |
Understanding Journey Medical Corp requires distinguishing between market price and book value, where the latter reflects Journey's accounting equity. The concept of intrinsic value - what Journey Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Journey Medical's price substantially above or below its fundamental value.
It's important to distinguish between Journey Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Journey Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Journey Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.